- Home
- USPH vs HROW Comparison
USPH vs HROW Comparison
Compare USPH & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USPH
- HROW
- Stock Information
- Founded
- USPH 1990
- HROW 1998
- Country
- USPH United States
- HROW United States
- Employees
- USPH N/A
- HROW N/A
- Industry
- USPH Medical/Nursing Services
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- USPH Health Care
- HROW Health Care
- Exchange
- USPH Nasdaq
- HROW Nasdaq
- Market Cap
- USPH 1.1B
- HROW 1.1B
- IPO Year
- USPH 1992
- HROW N/A
- Fundamental
- Price
- USPH $74.36
- HROW $30.66
- Analyst Decision
- USPH Strong Buy
- HROW Strong Buy
- Analyst Count
- USPH 4
- HROW 6
- Target Price
- USPH $109.00
- HROW $59.00
- AVG Volume (30 Days)
- USPH 165.1K
- HROW 433.0K
- Earning Date
- USPH 08-12-2025
- HROW 08-06-2025
- Dividend Yield
- USPH 2.42%
- HROW N/A
- EPS Growth
- USPH 81.25
- HROW N/A
- EPS
- USPH 2.17
- HROW N/A
- Revenue
- USPH $692,325,000.00
- HROW $212,858,000.00
- Revenue This Year
- USPH $16.68
- HROW $44.92
- Revenue Next Year
- USPH $6.05
- HROW $38.12
- P/E Ratio
- USPH $33.94
- HROW N/A
- Revenue Growth
- USPH 14.30
- HROW 53.49
- 52 Week Low
- USPH $62.77
- HROW $19.31
- 52 Week High
- USPH $101.20
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- USPH 44.79
- HROW 57.58
- Support Level
- USPH $73.59
- HROW $30.01
- Resistance Level
- USPH $78.01
- HROW $31.63
- Average True Range (ATR)
- USPH 2.01
- HROW 1.59
- MACD
- USPH -0.45
- HROW 0.02
- Stochastic Oscillator
- USPH 11.31
- HROW 66.10
About USPH U.S. Physical Therapy Inc.
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.